In vitro cytochrome P450‐ and transporter‐mediated drug interaction potential of 6β‐hydroxy‐21‐desacetyl deflazacort-A major human metabolite of deflazacort

• Egile Nagusiak: Jiyuan Ma (Egilea), Brian Beers (Egilea), Ravi Manohar (Egilea), Stephen Roe (Egilea), Joseph M. Colacino (Egilea), Ronald Kong (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2021-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract 6β‐Hydroxy‐21‐desacetyl deflazacort (6β‐OH‐21‐desDFZ) is a major circulating but not biologically active metabolite of deflazacort (DFZ). In vitro studies were performed to evaluate cytochrome P450 (CYP)‐ and transporter‐mediated drug interaction potentials of 6β‐OH‐21‐desDFZ. Up to 50 µM,...